Downs Christopher
SEC CIK 1705978 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CNSP | CNS Pharmaceuticals, Inc. | CFO | 103.4K | $74.1K | — | 7 | 2021-11-19 | 2024-02-01 |
Most active insiders at CNSP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Charles Faith L. | Dir | $34.0K | — |
| 2 | Fisher Michal | Dir | $10.0K | — |
| 3 | Levin Rami | CEO, Pres | — | — |
Downs Christopher made no open-market trades at CNSP in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-06 | 2024-02-01 | CNSP | CNS Pharmaceuticals, Inc. | Downs Christopher | CFO | P - Purchase | $0.3 | +66.7K | 103.4K | +181% | +$20.0K |
| 2023-08-23 | 2023-08-22 | CNSP | CNS Pharmaceuticals, Inc. | Downs Christopher | CFO | P - Purchase | $1.27 | +27.0K | 36.8K | +276% | +$34.3K | |
| D | 2023-05-01 | 2023-04-28 | CNSP | CNS Pharmaceuticals, Inc. | Downs Christopher | CFO | M - OptEx | — | +521 | 9,772 | +6% | — |
| 2023-04-18 | 2023-04-17 | CNSP | CNS Pharmaceuticals, Inc. | Downs Christopher | CFO | P - Purchase | $3.20 | +3,100 | 9,251 | +50% | +$9,920 | |
| 2022-03-14 | 2022-03-11 | CNSP | CNS Pharmaceuticals, Inc. | Downs Christopher | CFO | A - Grant | $0.31 | +33.0K | 184.5K | +22% | +$10.2K | |
| 2021-12-07 | 2021-12-06 | CNSP | CNS Pharmaceuticals, Inc. | Downs Christopher | CFO | P - Purchase | $0.94 | +5,000 | 151.5K | +3% | +$4,700 | |
| 2021-11-22 | 2021-11-19 | CNSP | CNS Pharmaceuticals, Inc. | Downs Christopher | CFO | P - Purchase | $1.15 | +4,500 | 146.5K | +3% | +$5,175 |
Purchase Sale Sale after option exercise All abbreviations